NCT02545127: A reported trial by Ferring Pharmaceuticals
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02545127 |
|---|---|
| Title | A Randomized, Double-blind, Placebo-controlled, Multicenter Trial Exploring the Efficacy and Safety of Intra-nasal Administration of Merotocin in Increasing Milk Production in Maternal Subjects With Preterm Delivery and Inadequate Milk Production |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 28, 2021 |
| Completion date | Nov. 11, 2022 |
| Required reporting date | Nov. 11, 2023, midnight |
| Actual reporting date | Nov. 2, 2023 |
| Date last checked at ClinicalTrials.gov | Feb. 6, 2026 |
| Days late | None |